Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Clean Vision (CLNV) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Clean Vision (CLNV) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Clean Vision's Cash & Equivalents rose 4726088.52% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 4726088.52%. This contributed to the annual value of $1.3 million for FY2024, which is 28315.73% up from last year.
  • Per Clean Vision's latest filing, its Cash & Equivalents stood at $2.0 million for Q3 2025, which was up 4726088.52% from $3.5 million recorded in Q2 2025.
  • Over the past 5 years, Clean Vision's Cash & Equivalents peaked at $3.5 million during Q2 2025, and registered a low of $4180.0 during Q3 2024.
  • For the 3-year period, Clean Vision's Cash & Equivalents averaged around $1.0 million, with its median value being $394304.0 (2023).
  • Per our database at Business Quant, Clean Vision's Cash & Equivalents plummeted by 9968.3% in 2024 and then surged by 4726088.52% in 2025.
  • Quarter analysis of 3 years shows Clean Vision's Cash & Equivalents stood at $339921.0 in 2023, then skyrocketed by 283.16% to $1.3 million in 2024, then surged by 52.0% to $2.0 million in 2025.
  • Its Cash & Equivalents stands at $2.0 million for Q3 2025, versus $3.5 million for Q2 2025 and $1.8 million for Q1 2025.